Are there any side effects when combining ezetimibe and vascepa?

Known Interactions Between Ezetimibe and Vascepa

No major pharmacokinetic interactions occur between ezetimibe (a cholesterol absorption inhibitor) and Vascepa (icosapent ethyl, a purified EPA omega-3). Clinical studies and drug interaction checkers report no significant changes in blood levels or efficacy when combined, as both target lipids via different pathways—ezetimibe blocks intestinal cholesterol uptake, while Vascepa reduces triglycerides through PPAR activation.[1][2]

Common Side Effects of Each Drug Alone

• Ezetimibe: Diarrhea (4-5%), upper respiratory infection (4%), joint pain (3%), fatigue (2-3%). Rare serious effects include liver enzyme elevation or allergic reactions.[3]
  
• Vascepa: Joint pain (11% vs. 10% placebo), diarrhea/gastrointestinal issues (9-15%), atrial fibrillation risk (especially in patients with prior heart rhythm issues).[4]
  
  Patients often tolerate the combo well, with overlapping mild GI symptoms like diarrhea noted in post-marketing reports, but no amplified frequency beyond individual use.[2][5]
  
  

Potential Risks When Combined

• Bleeding risk: Vascepa slightly increases bleeding time; ezetimibe does not. No heightened risk together unless on anticoagulants like warfarin—monitor INR if applicable.[1][6]
  
• Muscle pain (myopathy): Both can cause joint/muscle discomfort independently; rare reports of additive effects in combination therapy, though not statistically significant in trials.[5]
  
• Liver effects: Minimal risk; monitor ALT/AST if history of liver disease.
  No increased cardiovascular events or severe adverse reactions documented in large trials like REDUCE-IT (Vascepa) or IMPROVE-IT (ezetimibe/simvastatin, no Vascepa arm).[4][7]
  
  

What Patients Report and Clinical Monitoring

Real-world data from forums and databases like Drugs.com show occasional complaints of worsened GI upset or fatigue, but these resolve without stopping therapy. Doctors recommend baseline lipid panels and periodic checks for muscle symptoms or bleeding. Consult a physician before starting, especially with fish oil allergies or surgical plans—Vascepa requires discontinuation 7 days pre-op.[2][8]

Alternatives if Side Effects Occur

Switch to rosuvastatin + fenofibrate for similar lipid control, or add bempedoic acid to ezetimibe. For triglycerides alone, consider Lovaza (mixed omega-3s), which has more GI overlap.[3][6]

[1]: Drugs.com Interaction Checker
[2]: FDA Vascepa Label
[3]: FDA Zetia (Ezetimibe) Label
[4]: Bhatt DL et al., REDUCE-IT Trial, NEJM 2019
[5]: Medscape Drug Interaction Tool
[6]: Lexicomp Online Drug Interactions
[7]: Cannon CP et al., IMPROVE-IT Trial, NEJM 2015
[8]: eHealthMe User Reports (FAERS database analysis)